- Helps in controlling blood sugar levels in patients with type 2 diabetes.
- Reduces the risk of cardiovascular events associated with diabetes.
- Promotes weight loss or weight maintenance in overweight individuals.
- Improves insulin sensitivity and decreases hepatic glucose production.
- Facilitates better glycemic control when used alongside diet and exercise.
- May reduce the need for insulin therapy in some patients.
- Offers a convenient once-daily dosing schedule for ease of use.
Empadome M 12.5/1000 Tablet - Strip of 10
Compositions : Empagliflozin 12.5mg + Metformin Hydrochloride 1000mg
MRP :
MRP :
Out of stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Auxesia Life Sciences Pvt Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Empadome M 12.5/1000 Tablet is a pharmaceutical product designed to provide effective management of specific health conditions. This medication combines two active ingredients: Empagliflozin and Metformin, which work synergistically to help control blood sugar levels in patients with type 2 diabetes. Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, functions by preventing glucose reabsorption in the kidneys, thereby promoting its excretion through urine. Metformin, on the other hand, is a biguanide that enhances insulin sensitivity and decreases hepatic glucose production. Together, these components not only aid in glycemic control but also contribute to weight management and cardiovascular health. The formulation of Empadome M 12.5/1000 Tablet is specifically tailored for patients who require a dual-action approach to manage their diabetes effectively. It is available in tablet form, making it convenient for daily administration. The primary therapeutic purpose of this medication is to improve glycemic control in adults with type 2 diabetes, particularly when diet and exercise alone are insufficient. By integrating Empadome M 12.5/1000 Tablet into their treatment regimen, patients can achieve better overall health outcomes and reduce the risk of diabetes-related complications. Regular monitoring and consultation with healthcare professionals are essential to ensure optimal use of this medication, as individual responses may vary based on various factors such as lifestyle, diet, and concurrent medical conditions.
Product Details
- Empagliflozin inhibits the SGLT2 protein in the kidneys, leading to increased glucose excretion.
- Metformin enhances insulin sensitivity and reduces glucose production in the liver.
- Together, they help lower blood sugar levels effectively.
- Empagliflozin may also promote mild diuresis, contributing to weight loss.
- The combination helps address multiple aspects of type 2 diabetes management.
- Take Empadome M 12.5/1000 Tablet orally with or without food.
- The usual starting dose is one tablet once daily, as prescribed by your healthcare provider.
- Dosage may be adjusted based on individual response and blood sugar levels.
- It is important to take the tablet at the same time each day for consistency.
- Do not crush or chew the tablet; swallow it whole with water.
- Continue taking this medication as directed, even if you feel well.
- Consult your doctor if you miss a dose; do not double up on doses.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables to support blood sugar control.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to track your response to the medication.
- Avoid excessive alcohol consumption, as it can affect blood sugar levels.
- Stay hydrated by drinking plenty of water throughout the day.
- Work closely with your healthcare team to adjust your treatment plan as needed.
Safety Advice
Side Effects
- Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort.
- Some patients may experience urinary tract infections or genital fungal infections due to increased glucose in urine.
- Serious side effects can include dehydration, low blood sugar (hypoglycemia), and lactic acidosis.
- If you experience symptoms like unusual tiredness, muscle pain, or difficulty breathing, seek medical attention immediately.
- Regular monitoring of kidney function is recommended while on this medication.
Precautions and Warnings
- Avoid alcohol consumption while taking this medication due to potential interactions.
- Inform your doctor if you are pregnant or breastfeeding before starting treatment.
- Use caution when driving or operating machinery until you know how this medication affects you.
- Patients with kidney or liver issues should consult their healthcare provider before use.
- Monitor for signs of low blood sugar, especially if combined with other antidiabetic medications.
FAQs
If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once.
2. Can I take Empadome M 12.5/1000 Tablet if I am pregnant?
Empadome M 12.5/1000 Tablet is not recommended during pregnancy. Consult your healthcare provider for alternative options.
3. Are there any food interactions with Empadome M 12.5/1000 Tablet?
There are no specific food interactions; however, maintaining a balanced diet is crucial for managing diabetes effectively.
4. Who should avoid using Empadome M 12.5/1000 Tablet?
Individuals with severe kidney impairment or those with a history of hypersensitivity to its components should avoid this medication.
5. How should I store Empadome M 12.5/1000 Tablet?
Store the tablets at room temperature away from moisture and heat, and keep them out of reach of children.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 521046 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Auxesia Life Sciences Pvt Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Empadome M 12.5/1000 Tablet is a pharmaceutical product designed to provide effective management of specific health conditions. This medication combines two active ingredients: Empagliflozin and Metformin, which work synergistically to help control blood sugar levels in patients with type 2 diabetes. Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, functions by preventing glucose reabsorption in the kidneys, thereby promoting its excretion through urine. Metformin, on the other hand, is a biguanide that enhances insulin sensitivity and decreases hepatic glucose production. Together, these components not only aid in glycemic control but also contribute to weight management and cardiovascular health. The formulation of Empadome M 12.5/1000 Tablet is specifically tailored for patients who require a dual-action approach to manage their diabetes effectively. It is available in tablet form, making it convenient for daily administration. The primary therapeutic purpose of this medication is to improve glycemic control in adults with type 2 diabetes, particularly when diet and exercise alone are insufficient. By integrating Empadome M 12.5/1000 Tablet into their treatment regimen, patients can achieve better overall health outcomes and reduce the risk of diabetes-related complications. Regular monitoring and consultation with healthcare professionals are essential to ensure optimal use of this medication, as individual responses may vary based on various factors such as lifestyle, diet, and concurrent medical conditions.
- Helps in controlling blood sugar levels in patients with type 2 diabetes.
- Reduces the risk of cardiovascular events associated with diabetes.
- Promotes weight loss or weight maintenance in overweight individuals.
- Improves insulin sensitivity and decreases hepatic glucose production.
- Facilitates better glycemic control when used alongside diet and exercise.
- May reduce the need for insulin therapy in some patients.
- Offers a convenient once-daily dosing schedule for ease of use.
- Empagliflozin inhibits the SGLT2 protein in the kidneys, leading to increased glucose excretion.
- Metformin enhances insulin sensitivity and reduces glucose production in the liver.
- Together, they help lower blood sugar levels effectively.
- Empagliflozin may also promote mild diuresis, contributing to weight loss.
- The combination helps address multiple aspects of type 2 diabetes management.
- Take Empadome M 12.5/1000 Tablet orally with or without food.
- The usual starting dose is one tablet once daily, as prescribed by your healthcare provider.
- Dosage may be adjusted based on individual response and blood sugar levels.
- It is important to take the tablet at the same time each day for consistency.
- Do not crush or chew the tablet; swallow it whole with water.
- Continue taking this medication as directed, even if you feel well.
- Consult your doctor if you miss a dose; do not double up on doses.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables to support blood sugar control.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to track your response to the medication.
- Avoid excessive alcohol consumption, as it can affect blood sugar levels.
- Stay hydrated by drinking plenty of water throughout the day.
- Work closely with your healthcare team to adjust your treatment plan as needed.
Side Effects
- Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort.
- Some patients may experience urinary tract infections or genital fungal infections due to increased glucose in urine.
- Serious side effects can include dehydration, low blood sugar (hypoglycemia), and lactic acidosis.
- If you experience symptoms like unusual tiredness, muscle pain, or difficulty breathing, seek medical attention immediately.
- Regular monitoring of kidney function is recommended while on this medication.
Precautions and Warnings
- Avoid alcohol consumption while taking this medication due to potential interactions.
- Inform your doctor if you are pregnant or breastfeeding before starting treatment.
- Use caution when driving or operating machinery until you know how this medication affects you.
- Patients with kidney or liver issues should consult their healthcare provider before use.
- Monitor for signs of low blood sugar, especially if combined with other antidiabetic medications.
If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once.
2. Can I take Empadome M 12.5/1000 Tablet if I am pregnant?
Empadome M 12.5/1000 Tablet is not recommended during pregnancy. Consult your healthcare provider for alternative options.
3. Are there any food interactions with Empadome M 12.5/1000 Tablet?
There are no specific food interactions; however, maintaining a balanced diet is crucial for managing diabetes effectively.
4. Who should avoid using Empadome M 12.5/1000 Tablet?
Individuals with severe kidney impairment or those with a history of hypersensitivity to its components should avoid this medication.
5. How should I store Empadome M 12.5/1000 Tablet?
Store the tablets at room temperature away from moisture and heat, and keep them out of reach of children.
Directions for Use
Storage and Disposal
| SKU | 521046 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Auxesia Life Sciences Pvt Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account